本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

16.07
-0.5800-3.48%
成交量:65.93万
成交额:1,070.44万
市值:23.34亿
市盈率:-6.25
高:16.64
开:16.53
低:15.74
收:16.65
数据加载中...
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities